kt 5823 has been researched along with epidermal growth factor in 1 studies
Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
---|---|---|---|---|---|
317 | 0 | 59 | 24,155 | 217 | 4,699 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clementi, E; Meldolesi, J; Miloso, M; Nisticò, G; Riccio, M; Sciorati, C | 1 |
1 other study(ies) available for kt 5823 and epidermal growth factor
Article | Year |
---|---|
Nitric oxide action on growth factor-elicited signals. Phosphoinositide hydrolysis and [Ca2+]i responses are negatively modulated via a cGMP-dependent protein kinase I pathway.
Topics: Alkaloids; Calcium; Carbazoles; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Epidermal Growth Factor; Fibroblast Growth Factors; Growth Substances; GTP-Binding Proteins; Humans; In Vitro Techniques; Indoles; Ionomycin; Nitric Oxide; Phosphatidylinositols; Platelet-Derived Growth Factor; Signal Transduction | 1995 |